Combining Organoid Models with Next-Generation Sequencing to Reveal Tumor Heterogeneity and Predict Therapeutic Response in Breast Cancer

Estrogen receptor-positive (ER+) breast cancer (BC) is a common subtype of BC with a relatively good prognosis. However, recurrence and death from ER+ BC occur because of tumor heterogeneity. This study aimed to explore tumor heterogeneity using next-generation sequencing (NGS) and tumor-organoid mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuhong, Gan, Yixiang, AiErken, NiJiati, Chen, Wei, Zhang, Shiwei, Ouyang, Jie, Zeng, Leli, Tang, Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423951/
https://www.ncbi.nlm.nih.gov/pubmed/36046364
http://dx.doi.org/10.1155/2022/9390912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423951/
https://www.ncbi.nlm.nih.gov/pubmed/36046364
http://dx.doi.org/10.1155/2022/9390912

Ejemplares similares